GPT and metabolic dysfunction-associated steatotic liver disease: Additionally, the significant impact of LOW-HIIT on some liver enzymes detected in the present study is in line with our previous findings showing improvements in ALT serum concentrations and the non-alcohol fatty liver disease (NAFLD) fibrosis score in obese metabolic syndrome patients, who performed 12 weeks of LOW-HIIT [23].